Cubico, Maricel F.

HRN: 21-80-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
CEFUROXIME 750MG (VIAL)
09/15/2022
09/15/2022
IV
750 Mg
Q8
S/P Pelvic Lap

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines